RECRUITING

Beneficial Exposome Study

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to explore the positive, holistic health outcomes resulting from regular exposure to naturally occurring compounds predicted to have health benefits. The researchers hope to learn how the human body is influenced by regular exposure to these compounds.

Official Title

Beneficial Exposome: Investigating Its Effect on Human Health

Quick Facts

Study Start:2024-04-16
Study Completion:2026-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06093464

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older
  2. * Read, speak, and understand English
  3. * Live in the US territory
  1. * Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol
  2. * Is pregnant
  3. * Is breastfeeding
  4. * Has epilepsy
  5. * Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia

Contacts and Locations

Study Contact

Ji Hyun Kim, MS
CONTACT
(650) 441-6216
jikimji@stanford.edu
Allison Zhang, PhD
CONTACT
zhangxy@stanford.edu

Principal Investigator

Michael Snyder, PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University
Palo Alto, California, 94304
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Michael Snyder, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-16
Study Completion Date2026-04

Study Record Updates

Study Start Date2024-04-16
Study Completion Date2026-04

Terms related to this study

Additional Relevant MeSH Terms

  • Healthy